industryFebruary 28, 2026· Nasdaq / Google News
TransMedics Stock: A High-Tech Organ Transplant Moonshot?
TransMedics, the maker of the Organ Care System (OCS) for ex-vivo organ perfusion, is attracting investor attention as a high-growth play in transplant technology. The company's portable perfusion devices are expanding the geographic reach of organ procurement by keeping organs viable during longer transport times — a direct impact on OPO logistics and donor utilization rates.
Topics
transmedicsmachine perfusionorgan care systeminvestmenttechnology
Read original source
Opens Nasdaq / Google News in a new tab